Clinical trial
WATCHMAN LAAC Device Implantation During Hybrid Atrial Fibrillation Ablation
NCT02471131 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- WATCHMAN LAAC Device Implantation During Hybrid Atrial Fibrillation Ablation
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.